If you are a medical marijuana patient living in America, the initial euphoria of weed legalization in a dozen of states must have washed off by now. In fact, things might even seem more confusing than ever, as cannabis use remains illegal under federal law.
This confusion is what US Senator Kirsten Gillibrand seeks to end as she spoke in an industry summit hosted by the National Cannabis Industry Association last September 21.
“There’s a conflict between state and federal statute that confuses doctors, patients, and providers alike. People aren’t sure what’s legal, what’s not, and the gray area that resulted is hindering health care and the industry’s development,” she said.
She told the audience that she is pushing for reforms under the Compassionate Access, Research Expansion, and Respect State Act that she introduced last March, together with Democratic Senator Cory Brooker of New Jersey and Republican Senator Rand Paul of Kentucky.
“It would finally allow families and patients, including our veterans in 40 states that have some form of legalized medical marijuana, to access the basic care that they need without fear of prosecution,” Gillibrand said.
The act would allow states to set their own policies so that families benefiting from medical weed no longer have to fear federal prosecution. The reforms will also help expand the limited financial services that marijuana businesses are getting.
At the moment, marijuana is federally classified as a Schedule I drug, meaning the drug is illegal and has no accepted medical use. Bipartisan proposals are intending to make it a Schedule II drug to recognize that it has legitimate health purposes, with states implementing their own programs.
What kind of federal cannabis reforms would you like to see? Voice your opinions in the comments section below – your opinion matters to the nation.